Chatham Capital Group Inc. Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Chatham Capital Group Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,882 shares of the healthcare conglomerate’s stock after buying an additional 679 shares during the period. Chatham Capital Group Inc.’s holdings in UnitedHealth Group were worth $5,383,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter worth approximately $5,802,231,000. International Assets Investment Management LLC grew its position in UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after acquiring an additional 2,348,107 shares during the period. Jennison Associates LLC grew its position in UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after acquiring an additional 1,195,352 shares during the period. California Public Employees Retirement System grew its position in UnitedHealth Group by 35.9% in the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after acquiring an additional 815,822 shares during the period. Finally, Public Employees Retirement Association of Colorado grew its position in UnitedHealth Group by 3,464.9% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after acquiring an additional 802,160 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on the company. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a research note on Wednesday, June 5th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Finally, Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Price Performance

UNH stock opened at $509.26 on Monday. The firm has a 50 day moving average of $498.34 and a 200-day moving average of $501.63. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $468.72 billion, a price-to-earnings ratio of 31.13, a PEG ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the firm earned $6.26 EPS. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a $2.10 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.